Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
CLYMthis companyClimb Bio, Inc.	$11.22	-4.55×	1.69×	0×	-3.95×	-95.0%	0.0%	0.0%	0.0%	-37.3%	-42.2%	-20.1%	0×	0.59×	0×	15.16×	0.0%	2	48.03	2	C
CABACabaletta Bio, Inc.	$1.47	-1.34×	2×	0×	-1.02×	-65.7%	0.0%	0.0%	0.0%	-149.8%	-123.8%	-59.1%	0.24×	0.34×	-85.95×	2.77×	0.0%	2	-1.41	2	C+
ELDNEledon Pharmaceuticals, Inc.	$2.77	-2.7×	1.52×	0×	-2.24×	-91.0%	0.0%	0.0%	0.0%	-56.3%	-55.1%	-50.4%	0.01×	0.49×	0×	7.4×	0.0%	1	-4.22	2	C
TRAXFirst Tracks Biotherapeutics Inc	$49.18	-3.98×	2.3×	0×	-2.47×	-85.9%	0.0%	0.0%	0.0%	-57.8%	-59.4%	-21.7%	0.05×	1.27×	0×	10.2×	0.0%	—	—	2	C
UPBUpstream Bio, Inc.	$3.51	-10.21×	4.3×	512.3×	-9.51×	-107.7%	100.0%	-5618.8%	-5026.0%	-42.2%	-47.0%	-9.1%	0×	0.7×	0×	26.15×	0.0%	2	7.6	2	C+
Peer median	—	-3.34×	2.15×	0×	-2.35×	-88.4%	0.0%	0.0%	0.0%	-57.0%	-57.2%	-36.1%	0.03×	0.59×	0×	8.8×	0.0%	2	-1.41	2	—